> Lilly said it was not raising the price paid by the NHS
That’s ok then. The usage through the NHS has to be the priority so people who have a genuine medical requirement for it come first — private users can decide if the price is worth paying.
chronicnerv on
It’s a genius and cynical business model. I always appreciate a good villainous plan when I see one.
70% of packaged foods contain added sugar, fuelling poor health and weight gain.
Then, weight loss drugs are sold to treat the very problems the food industry helped create.
This isn’t unique to food, I see the same mechanic in business decisions everywhere: create a problem, then profit by ‘solving’ it. The result? A profitable cycle of dependence.
Healeah241 on
Short term this is shit for those on it, but we’re fortunate that there is an increasing number of available glp-1 agonist drugs which should help competition and drive prices down.
the_phet on
It is important to read the reason why:
> Eli Lilly has raised the UK price of its popular weight loss drug Mounjaro by as much as 170 per cent, as it tries to address complaints by Donald Trump’s administration about “foreign freeloaders” who rely on the US to pay more for medicines.
I don’t use these medicines, but this is terrible. They are already making a lot of money. They only want to appease Trump.
> The price for a month’s supply of the highest doses of the drug will rise from £122 to £330, an increase of 170 per cent.
This is quite an insane jump. it is almost 3 times the price. For some reason I thought 170% would be a 70% more. But 3x is crazy.
jb8996 on
This has made me feel incredibly disappointed. I recently made a major decision for myself. After struggling with my weight for over a decade, I started Mounjaro this month. Even the initial loading dose has completely changed my relationship with food and I’m already experiencing benefits, not just in terms of weight loss but more energy, better sleep and generally feeling a lot better mentally. I’ll be able to continue the treatment despite the suggested price increases, but I’d worry that many others won’t be able to. Too many people may end up stopping the drug, regaining the weight, or turning to cheaper knock-offs from local beauticians or the black market. It feels like Eli Lilly has taken advantage of the UK public by getting us reliant on their product and whacking up the prices once we reap the rewards. One positive is this may trigger a race to the bottom on alternative medications and force Eli Lilly into a similar approach.
Acceptable-Pin2939 on
Well that’s the end of mounjaro in the UK.
I’m sure Eli Lilly are thrilled to lose the consumer market.
let_me_atom on
Probably for the best, it’s clearly being overused.
Logical-Brief-420 on
Honestly we could’ve seen this coming from a mile away given how effective these drugs are, not that it makes it any better for people.
I actually joked to friends and family months ago I’d have paid double the price that I actually paid if I knew from the start it would work as well as it did, although that was slightly tongue in cheek and I’m sure I’ll regret saying that now lol
There are lots of interesting GLP1s coming down the pipeline and I believe Ozempic comes off licence and can be produced as a generic in the not too distant future, so there is hope for future patients.
TokyoMegatronics on
i mean yeah. the idea is that rather than actually crush the pharmaceutical companies and insurance companies ruining US healthcare its to subsidize the cost by making everyone else in the world pay more
Hot_Chocolate92 on
Novo Nordisk who manufacture Ozempic should be rubbing their hands with glee. It’s still substantially cheaper Mounjaro and hopefully will continue to be. It doesn’t have the same results in terms of weight loss as Mounjaro, but still a very significant effect.
Eli Lilly if they aren’t careful will lose their consumer base.
gobred_gilfred_biago on
I’m personally glad I’ve finished my treatment a few months back. 45KG lost in a year and I didn’t really have to suffer at all. Shite for anyone on it now though.
Ok_Temporary_383 on
Back to fat acceptance we go, now that the fraudsters will gain weight again lol
baddymcbadface on
For those worried about this. Ensure to look into “counting clicks”. It’s a mechanism to buy a high dose but administer a low dose. You can cut the bill in half with this mechanism. Doctors in other countries support it. I doubt you’ll find a doctor in the UK who supports it.
Go to r/zepbound or r/mounjaro for more info.
(Zepbound is just the brand name in the us, same drug).
Acceptable-Pin2939 on
The implications of this are pretty staggering when you think about it.
Eli Lilly have effectively just said to the world “don’t buy our product because we will massively jack up the price at any moment”
Not a wise business move.
catman_dave on
Is wegovy not almost as good ? I presume if novo Nordisk don’t follow suit everyone will just switch to that instead
Pocktio on
Why am i not surprised an american pharmaceutical did this instead of reducing prices in America 🙄
YsoL8 on
So how long before ‘rest of the world’ based manufacturers use the massive disparity to rip US based manufacturers foreign sales to ribbons?
CDHmajora on
Ooooof. Thats gonna hurt their profits more than thry realise.
You’d rather sell to 4 people for £150 a head rather than losing 3 of yhose sales and only getting £300 from 1.
Doesnt matter though anyway. Eventually some UK or European based alternative will come out for a much lower price and drive this off the market anyway.
Fuck the yanks medical companies though.
wkavinsky on
I am of course shocked that the widely predicted “get em hooked and then jack the h price” model I s, in fact,, being filled to a T with this.
pommybear on
Just as it starts getting prescribed on the NHS. Funny that. Disappointed as somebody currently using it.
ClassOptimal7655 on
Isn’t there a term for when companies suddenly raise the prices? Price Gouging? Would there not be laws in the UK to prevent this?
DisorganisedPigeon on
Save your money and work on a healthy diet and exercise in the long run, your body will thank you. You want to maintain that lifestyle going forward instead of relying on this type of drug really
ydykmmdt on
Straight from the drug dealer’s playbook: Get them hooked then up the price.
Adorable_Pee_Pee on
Well that’s fucking shit. If I had hung on I’d be able to get it on the nhs by now as it is I am going to have to pay through the nose or come off it and pile back on the weight!
Aggressive-Bed597 on
Won’t the NHS and individuals just use an alternative weight loss drug..
SavageRabbitX on
Idiots that’s not gonna fly with how NHS procurement works they’ll just switch to alternative. Hell, the base medication is so old that it’s patent free from next year, so you could, in theory, just make generics
Zygersaf on
Well that sucks. In the UK it is actually quite “cheap”, in comparison the 10mg pen in Germany is 385Euro, where at the moment it’s 209GBP. This price raise will bring it inline with Europe I guess. Unless Europe is also getting the price rise then god damn it will be only affordable to the elite in that case!
27 commenti
> Lilly said it was not raising the price paid by the NHS
That’s ok then. The usage through the NHS has to be the priority so people who have a genuine medical requirement for it come first — private users can decide if the price is worth paying.
It’s a genius and cynical business model. I always appreciate a good villainous plan when I see one.
70% of packaged foods contain added sugar, fuelling poor health and weight gain.
Then, weight loss drugs are sold to treat the very problems the food industry helped create.
This isn’t unique to food, I see the same mechanic in business decisions everywhere: create a problem, then profit by ‘solving’ it. The result? A profitable cycle of dependence.
Short term this is shit for those on it, but we’re fortunate that there is an increasing number of available glp-1 agonist drugs which should help competition and drive prices down.
It is important to read the reason why:
> Eli Lilly has raised the UK price of its popular weight loss drug Mounjaro by as much as 170 per cent, as it tries to address complaints by Donald Trump’s administration about “foreign freeloaders” who rely on the US to pay more for medicines.
I don’t use these medicines, but this is terrible. They are already making a lot of money. They only want to appease Trump.
> The price for a month’s supply of the highest doses of the drug will rise from £122 to £330, an increase of 170 per cent.
This is quite an insane jump. it is almost 3 times the price. For some reason I thought 170% would be a 70% more. But 3x is crazy.
This has made me feel incredibly disappointed. I recently made a major decision for myself. After struggling with my weight for over a decade, I started Mounjaro this month. Even the initial loading dose has completely changed my relationship with food and I’m already experiencing benefits, not just in terms of weight loss but more energy, better sleep and generally feeling a lot better mentally. I’ll be able to continue the treatment despite the suggested price increases, but I’d worry that many others won’t be able to. Too many people may end up stopping the drug, regaining the weight, or turning to cheaper knock-offs from local beauticians or the black market. It feels like Eli Lilly has taken advantage of the UK public by getting us reliant on their product and whacking up the prices once we reap the rewards. One positive is this may trigger a race to the bottom on alternative medications and force Eli Lilly into a similar approach.
Well that’s the end of mounjaro in the UK.
I’m sure Eli Lilly are thrilled to lose the consumer market.
Probably for the best, it’s clearly being overused.
Honestly we could’ve seen this coming from a mile away given how effective these drugs are, not that it makes it any better for people.
I actually joked to friends and family months ago I’d have paid double the price that I actually paid if I knew from the start it would work as well as it did, although that was slightly tongue in cheek and I’m sure I’ll regret saying that now lol
There are lots of interesting GLP1s coming down the pipeline and I believe Ozempic comes off licence and can be produced as a generic in the not too distant future, so there is hope for future patients.
i mean yeah. the idea is that rather than actually crush the pharmaceutical companies and insurance companies ruining US healthcare its to subsidize the cost by making everyone else in the world pay more
Novo Nordisk who manufacture Ozempic should be rubbing their hands with glee. It’s still substantially cheaper Mounjaro and hopefully will continue to be. It doesn’t have the same results in terms of weight loss as Mounjaro, but still a very significant effect.
Eli Lilly if they aren’t careful will lose their consumer base.
I’m personally glad I’ve finished my treatment a few months back. 45KG lost in a year and I didn’t really have to suffer at all. Shite for anyone on it now though.
Back to fat acceptance we go, now that the fraudsters will gain weight again lol
For those worried about this. Ensure to look into “counting clicks”. It’s a mechanism to buy a high dose but administer a low dose. You can cut the bill in half with this mechanism. Doctors in other countries support it. I doubt you’ll find a doctor in the UK who supports it.
Go to r/zepbound or r/mounjaro for more info.
(Zepbound is just the brand name in the us, same drug).
The implications of this are pretty staggering when you think about it.
Eli Lilly have effectively just said to the world “don’t buy our product because we will massively jack up the price at any moment”
Not a wise business move.
Is wegovy not almost as good ? I presume if novo Nordisk don’t follow suit everyone will just switch to that instead
Why am i not surprised an american pharmaceutical did this instead of reducing prices in America 🙄
So how long before ‘rest of the world’ based manufacturers use the massive disparity to rip US based manufacturers foreign sales to ribbons?
Ooooof. Thats gonna hurt their profits more than thry realise.
You’d rather sell to 4 people for £150 a head rather than losing 3 of yhose sales and only getting £300 from 1.
Doesnt matter though anyway. Eventually some UK or European based alternative will come out for a much lower price and drive this off the market anyway.
Fuck the yanks medical companies though.
I am of course shocked that the widely predicted “get em hooked and then jack the h price” model I s, in fact,, being filled to a T with this.
Just as it starts getting prescribed on the NHS. Funny that. Disappointed as somebody currently using it.
Isn’t there a term for when companies suddenly raise the prices? Price Gouging? Would there not be laws in the UK to prevent this?
Save your money and work on a healthy diet and exercise in the long run, your body will thank you. You want to maintain that lifestyle going forward instead of relying on this type of drug really
Straight from the drug dealer’s playbook: Get them hooked then up the price.
Well that’s fucking shit. If I had hung on I’d be able to get it on the nhs by now as it is I am going to have to pay through the nose or come off it and pile back on the weight!
Won’t the NHS and individuals just use an alternative weight loss drug..
Idiots that’s not gonna fly with how NHS procurement works they’ll just switch to alternative. Hell, the base medication is so old that it’s patent free from next year, so you could, in theory, just make generics
Well that sucks. In the UK it is actually quite “cheap”, in comparison the 10mg pen in Germany is 385Euro, where at the moment it’s 209GBP. This price raise will bring it inline with Europe I guess. Unless Europe is also getting the price rise then god damn it will be only affordable to the elite in that case!